AbbVie
AbbVie shares were changing hands at 256.46, down 1.44% on the day. Its market capitalisation is about 453.19B, the #24 most valuable US-listed company we track. Valuation-wise, the P/E sits at 72.45, 24% above the five-year average of 58.55. It pays a dividend yielding 2.63% on a trailing basis. The 23 analysts covering the stock are, on balance, at Buy, targeting an average of 282.85 (+10%). The shares sit 86% of the way up their 52-week range of 189.40 to 267.47.
✦ StockVane Quant Insights how this is computed
- Valuation sits at the 61% percentile of its own 5-year range.
- Price momentum averages +19.5% across the trailing 3-month/1-year windows.
- Analyst consensus across 23 analysts is Buy.
- Recent price momentum is +19.5% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 260.21
- Open
- 257.96
- Day range
- 255.58 - 258.91
- Avg price
- 256.62
- Volume
- 4.73M
- Turnover
- 1.21B
- Turnover rate
- 0.27%
- Volume ratio
- 1.26
- Amplitude
- 1.28%
- 52-week range
- 189.40 - 267.47
Valuation
- P/E
- 108.67
- P/E (TTM)
- 72.45
- P/B
- -76.35
- EPS
- 2.36
- Book value / sh
- -3.36
- Net profit
- 4.17B
- Net assets
- -5.94B
Share structure
- Market cap
- 453.19B
- Float cap
- 452.39B
- Shares out
- 1.77B
- Float shares
- 1.76B
Dividend & listing
- Div yield (TTM)
- 2.63%
- Dividend (TTM)
- 6.74
- Listing date
- 1970-01-01
4.1% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+99.72M net over the window
Short interest
- Shares short
- 18.30M
- % of float
- 1.04%
- Days to cover
- 3.57
- As of
- 2026-08-14
Frequently asked questions
What is the current stock price of AbbVie (ABBV)?
AbbVie last traded at 256.46. The quote on this page refreshes every few seconds while US markets are open.
What is AbbVie's market cap?
About 453.19B.
What is the P/E ratio of AbbVie?
The trailing twelve-month P/E is 72.45. The Valuation tab shows it against the stock's own five-year range.
Does AbbVie pay a dividend?
Yes. The trailing dividend yield is 2.63%. See the Dividends tab for the full payment history.
Is AbbVie a buy according to analysts?
The consensus of 23 analysts is a Buy rating, with an average 12-month price target of 282.85. This is not investment advice.
Quote time 2026-09-04 20:02:13
For reference only, not investment advice.